In spite of its initial celebration, the Trump administration appears to be wise to the fact that the industry's efforts at reform were pretty lazy.

This is a period of massive uncertainty for the PBM business, and Cigna is paying $54 billion for the pleasure of having to navigate it.

Buying Humana would put Walmart into some less familiar lines of business, but the Medicare piece does fit with its retail and pharmacy customer base.

Without having done much yet, Amazon.com Inc. is already transforming U.S. health care -- and not necessarily for the better.

Pharma's pricing power just isn't what it used to be, and it's probably not going to recover any time soon.

CVS's already costly deal looks even more expensive after its warning on Thursday of a possible profit decline this year, despite an expected $1.2 billion benefit from tax cuts. CVS shares fell though it reported positive quarterly results.

Pharma claims to like the free market, but in the year ahead, Gottlieb is set to prove how the free market can cut both ways for drugmakers.

President Donald Trump has said the GOP's tax bill "essentially repealed" Obamacare. He's wrong -- the Affordable Care Act will survive 2018 at least semi-intact.